Dr. Timo Kruger, fiagon CEO, commented, "The team at fiagon is excited to be working with the experienced ENT industry professionals at ENTrigue. We are encouraged by the possibilities."
The ENTrigue Ventera® Sinus Dilation System includes a single-use balloon delivered by one of several reusable instruments utilizing ENTrigue's proprietary SerpENT® articulating technology and does not require either manual tip shaping or the use of a guide wire or cannula to deliver the balloon into various sinuses. The Ventera® Sinus Dilation System is the only balloon system that can be inserted transnasally and then articulated in-place to best access any sinus cavity. The combination of real-time navigation with balloon dilation is expected to significantly enhance the capability of ENT surgeons to perform minimally invasive sinus surgery.
Fred Dinger, ENTrigue CEO, added, "Integrating fiagon's navigation to our sinus dilation platform will provide the ENT surgeon with an unparalleled level of confirmation of balloon position within the sinus anatomy. We look forward to collaborating with fiagon to combine two game-changing platforms with the goal of bringing easy-to-use, cost effective technologies to the sinus surgery market."
ENTrigue's Ventera® Sinus Dilation System with fiagon's Dynamic Navigation System will be on display in ENTrigue's booth at the upcoming American Academy of Otolaryngology-Head and Neck Surgery meeting in Washington, DC. The Ventera® Sinus Dilation System is presently available in only a limited number of countries in Europe and Canada and is not available for sale in the United States. The Dynamic Navigation System from fiagon is currently available in certain countries in Europe.
fiagon develops and manufactures a new generation of intelligent and highly portable navigation systems for ENT, oral and maxillofacial surgery and neurosurgery. The fiagon navigation system uses electromagnetic tracking matrix algorithms and unique flexible pointing devices to simplify the use of modern navigation and diagnostic tools in daily clinical routine.
Companies in this press-release
